Literature DB >> 24000650

[Sevoflurane optimal dosage estimation for myocardium pharmacological postconditioning: an experimental study].

A V Grishin, A G Iavorovskiĭ, I L Zhidkov, É R Charchian, A G Ivanova, M V Paliulina, N V Sitnichenko.   

Abstract

We estimated the optimal dosage of inhalation anesthetic sevoflurane, for the maximum cardioprotective effect with minimal angioparalytic action. 25 pigs were included in this study, they were divided into 5 groups, depending on the sevoflurane dosage used for pharmacological postconditioning (PPC): control group - PPC has't been conducted, a group of PPC 0.5 - sevoflurane PPC in a dose of 0.5 V%, a group of PPC 1.0 - sevoflurane PPC in a dose of 1.0 V%, a group of PPC 1.5 - sevoflurane PPC in a dose of 1.5 V%, a group of PPC 2.0 - sevoflurane PPC in a dose of 2.0 V%, a group of PPC 2.5 - sevoflurane PPC in a dose of 2.5 V%. Ischemia was simulated by left coronary artery crossclamping. Further PPC was held according to the following Protocol: 20 min before left coronary artery clamp off and first 20 min of reperfusion sevoflurane was given into CPB circuit. Myocardial ischemia period was 60 min in all groups. It was found and experimentally proved that the optimal sevoflurane dosage for PPC is 2 V%

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24000650

Source DB:  PubMed          Journal:  Anesteziol Reanimatol        ISSN: 0201-7563


  1 in total

1.  Cardioprotective effect of notoginsenoside R1 in a rabbit lung remote ischemic postconditioning model via activation of the TGF-β1/TAK1 signaling pathway.

Authors:  Zhi-Ru Ge; Mao-Chun Xu; Y U Huang; Chen-Jun Zhang; J E Lin; Chang-Wu Ruan
Journal:  Exp Ther Med       Date:  2016-04-04       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.